Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Interleukin-27 subunit beta (IL-27b) Peptide

IL-27b Reactivity: Human Host: Synthetic BP, BI
Catalog No. ABIN5686891
  • Target See all EBI3 (IL-27b) products
    EBI3 (IL-27b) (Interleukin-27 subunit beta (IL-27b))
    Origin
    Human
    Source
    • 4
    Synthetic
    Application
    Blocking Peptide (BP), BioImaging (BI)
    Characteristics
    EBI3 peptide corresponds to 15 amino acids near an internal region of EBI3.
  • Application Notes
    EBI3 Peptide is used for blocking the activity of EBI3 antibody . The EBI3 antibody ships at 0.5 mg/mL and the EBI3 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    EBI3 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Target
    EBI3 (IL-27b) (Interleukin-27 subunit beta (IL-27b))
    Target Type
    Viral Protein
    Gene ID
    10148
    NCBI Accession
    NP_005746
    OMIM
    14577917
    UniProt
    Q14213
You are here:
Support